Category: Prescription Drugs
North America Prescription Drugs
-
2024-2029 Global Drugs of Abuse Testing Market for 12 Assays - US, Europe, Japan - 2024 Supplier Shares and 2024-2029 Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers
... This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source . This new report from LeadingMarketResearch.com provides analysis of the global drug of abuse testing market, including emerging tests, ... Read More
-
Pharmaceuticals in the US: ISIC 2423
... ISIC 2423 market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of ... Read More
-
North America Dry Eye Disease Market Forecast 2024-2032
... valued at $2283.72 million in 2032, reaching a projected revenue of $3604.57 million by 2032. MARKET INSIGHTS The rising geriatric population in North America is a significant factor contributing to the growing number of cases ... Read More
-
Swine Health
... at a CAGR of 5.8% over the analysis period 2023-2030. Antibiotics, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$2.5 Billion by the end of the ... Read More
-
Brand Name Pharmaceutical Manufacturing in the US - Industry Market Research Report
... launches, with over 28 novel drugs approved in 2022 (latest data available). Given increasing price scrutiny, competition from generics, intensifying market competition among brand-name producers and rising research and development expenses, many manufacturers have shifted ... Read More
-
Cough, Cold and Allergy (Hay Fever) Remedies in the US
... normalisation after the extreme double-digit growth brought about by the “tripledemic” in 2022. While most paediatric and adult cough and cold categories are expected to see slight negative growth in 2024, overall decline is mainly ... Read More
-
Compounding Pharmacies in the US - Industry Market Research Report
... the broader Healthcare and Social Assistance sector. Compounded medications can address patients' noncompliance with their medication by offering tastes, routes of administration and dosages that are not otherwise commercially available. The aging population has stimulated ... Read More
-
Medication Management Systems
... by 2030, growing at a CAGR of 9.9% over the analysis period 2023-2030. Inventory Management Solutions, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$2.2 Billion ... Read More
-
Sleeping Aids
... at a CAGR of 5.3% over the analysis period 2023-2030. Sleep Apnea Devices, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$36.9 Billion by the end ... Read More
-
Mild Cognitive Impairment Market Research Report By Disease Type (Amnestic MCI and Non-Amnestic MCI), By Age (Child, Adult, Geriatric), By Indication (Lewy Body Dementia, Parkinson’s Disease Dementia, Alzheimer’s Disease, Vascular Dementia, and Others) By Treatment (Medication (Cholinesterase Inhibitors, Benzodiazepines, Glutamate Inhibitors, Antihistamines, Mao Inhibitors, Proton Pump Inhibitors, and Others), Therapy (Cognitive Stimulation Therapy, Cognitive Behavioural Therapy (CBT)), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World – Industry Forecast Till 2032
... (Medication (Cholinesterase Inhibitors, Benzodiazepines, Glutamate Inhibitors, Antihistamines, Mao Inhibitors, Proton Pump Inhibitors, and Others), Therapy (Cognitive Stimulation Therapy, Cognitive Behavioural Therapy (CBT)), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World – ... Read More
-
Pharmacy Market in Us 2024-2028
... market in US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
Brand Name Pharmaceutical Manufacturing in the US - Industry Market Research Report
... launches, with over 28 novel drugs approved in 2022 (latest data available). Given increasing price scrutiny, competition from generics, intensifying market competition among brand-name producers and rising research and development expenses, many manufacturers have shifted ... Read More
-
Animal Health Market In North America 2024-2028
... report on the animal health market in North America provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an ... Read More
-
Compounding Pharmacies in the US - Industry Market Research Report
... the broader Healthcare and Social Assistance sector. Compounded medications can address patients' noncompliance with their medication by offering tastes, routes of administration and dosages that are not otherwise commercially available. The aging population has stimulated ... Read More
-
Multiple Myeloma Therapeutics
... by 2030, growing at a CAGR of 14.6% over the analysis period 2023-2030. Chemotherapy & Other Drugs, one of the segments analyzed in the report, is expected to record a 15.4% CAGR and reach US$37.6 ... Read More
-
Cannabis Production in Canada - Industry Market Research Report
... Canada opened up medicinal cannabis production to more players in 2013, producers have grown continuously as they invest in production capabilities to produce quality products. As consumers shifted from illegal cannabis purchases to the licensed ... Read More
-
United States Pain Management Therapeutics Market and Forecast Therapeutics (Devices and Pharmaceuticals), Pain Type, Drug Class, Indication, Distribution Channel and Company Analysis 2024-2032
... Therapeutics Market will reach US$ 36.15 billion by 2032, up from US$ 26.18 billion in 2023, with a CAGR of 3.65% between 2024 and 2032. Many factors are driving the market's rapid expansion such as ... Read More
-
US Oral Antiviral Market Size study, by Indication (Hepatitis, Human Immunodeficiency Virus (HIV), Influenza, Others) by Drug Class (Protease inhibitors, Reverse transcriptase inhibitors, Others) by Distribution Channel (Hospital pharmacies, Drug store and retail pharmacies, Online providers) Forecasts 2022-2032
... providers) Forecasts 2022-2032 US Oral Antiviral Market is valued approximately USD 9.98 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 1.69% over the forecast period 2024-2032. Oral ... Read More
-
Healthcare Consultants in the US - Industry Market Research Report
... manage risk. Over the five years to 2023, demand for healthcare consultants has increased because of technological advances in healthcare-related industries and the changing regulatory environment. Moreover, the 2010 Patient Protection and Affordable Care Act ... Read More
-
US Neuroblastoma Drugs Market Size study, by Type (Chemotherapy, Immunotherapy, Others), By Route of Administration (Oral, Injectable), By Distribution Channel (Online, Offline), Forecasts 2022-2032
... 2023 and is anticipated to grow with a healthy growth rate of more than 7.11% over the forecast period 2024-2032. Neuroblastoma is a cancer primarily occurring in young children under five years old, originating in ... Read More
-
Contract Research Organizations in the US - Industry Market Research Report
... for Food and Drug Administration (FDA) approval. An explosion in research and development investment, frustratingly high clinical trial costs and an uptick in patent expirations have driven pharmaceutical companies to outsource clinical trial management. These ... Read More
-
Addiction Treatment Market, By Type (Alcohol Addiction, Tobacco/Nicotine Addiction, Opioid Addiction, and Others), By Drug Type (Opioids (Buprenorphine, Methadone, Naltrexone), Nicotine Replacement Therapies (Nicotine Gums, Nicotine Patches, Nicotine Lozenges, Non-Nicotine Medication, Varenicline, and Bupropion), By Distribution Channel (Hospital Pharmacies, Medical Stores, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)
... Distribution Channel (Hospital Pharmacies, Medical Stores, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa) Addiction is a chronic health condition that affects millions globally. It impacts individuals physically ... Read More
-
North America & Europe Epilepsy Market Research Report Information Forecast to 2032 Based on Condition (Generalized Epilepsy and Focal Epilepsy), By diagnosis & treatment, By End User (hospitals & clinics, diagnostic centers, and others), By Region (US, Canada, Europe).
... (US, Canada, Europe) It is projected that the epilepsy market in North America and Europe would increase at a strong rate throughout the study period, with a compound annual growth rate of 8.18%. Recurrent seizures ... Read More
-
United States Sex Reassignment Hormone Therapy Market By Gender Transition (Male-To-Female, Female-To-Male), By Type (Puberty Blockers, Estrogen, Testosterone), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) Region and Competition, Opportunity, and Forecast, 2019-2029F
... States Sex Reassignment Hormone Therapy Market was valued at USD 1.21 billion in 2023 and is anticipated tproject steady growth in the forecast period with a CAGR of 4.29% through 2029. The United States Sex ... Read More
-
North America Cold Sore Treatment (for HSV 1 Virus) Market
... growing at the CAGR of 7.2% in the forecast period of 2024 to 2031. Market Segmentation North America Cold Sore Treatment (for HSV 1 Virus) Market, By Treatment Type (Medications, Applied Products, Cold Sore Patches, ... Read More